Aster DM Healthcare reports strong Q2 FY26 amid strategic expansion

Aster DM Healthcare reported a 10% year-on-year and 11% quarter-on-quarter increase in Q2 FY26 revenue to INR 1,197 crores, with operating EBITDA up 13% YoY and 22% QoQ to INR 263 crores. Normalised PAT (Post NCI) also grew 14% YoY and 23% QoQ to INR 110 crores. The Kerala cluster achieved its highest-ever quarterly revenue of INR 620 crores, supported by a 12% QoQ inpatient volume growth. The newly operationalized 264-bedded Aster Kasaragod will further strengthen its northern Kerala presence.

The board of directors approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. Corporate changes include the resignation of Anoop Moopen as non-executive director due to other business commitments, effective November 6, 2025, and the induction of T.J. Wilson as a member of the nomination and remuneration committee. The company is also shifting its registered office to Hyderabad, Telangana.

Strategic updates include the approval of 467,500 employee stock options under the ESOP Plan 2013, the acquisition of an additional 12.99% stake in Dr. Ramesh Cardiac and Multispeciality Hospital Private Limited for INR 62.91 crores, increasing shareholding to 70.48%, and investments in two new wholly-owned subsidiaries for super-specialty hospitals in Sarjapur (INR 50.01 crores) and Yeswanthpur (INR 0.01 crore). The merger with Quality Care India Ltd. received stock exchange no-objection letters, with closing contingent on NCLT and shareholder approval.